Market Place
Sourcing Support
ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer
04 Jan 2024 //
BUSINESSWIRE
Rome’s ‘dark genome’ drug reduces autoimmune markers in mice
17 Nov 2023 //
FIERCE BIOTECH
Rome advances dark genome drug after completing $72M Series B extension
12 Sep 2023 //
ENDPTS
ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension
12 Sep 2023 //
BUSINESSWIRE
Rome builds out investor syndicate with J&J, BMS
12 Sep 2023 //
FIERCE BIOTECH
ROME Appoints Keith Wilcoxen, Ph.D., as Executive Vice President
09 Mar 2023 //
BUSINESSWIRE
ROME & Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry
02 Nov 2022 //
BUSINESSWIRE
ROME Tx Appoints Industry Veteran Jeff Hatfield as Chair of Board of Directors
18 Jul 2022 //
BUSINESSWIRE
ROME Therapeutics Shows Preclinical Data Demonstrating Inhibition of eRT
08 Nov 2021 //
BUSINESSWIRE
ROME Therapeutics Secures $77M in Series B Financing to Advance its Pipeline
14 Sep 2021 //
BUSINESSWIRE
ROME Expands Science Leadership in Oncology
19 Jul 2021 //
BUSINESSWIRE
Rome hires science leaders to find targets in “junk DNA”
19 Jul 2021 //
FIERCEBIOTECH
Rome snags Merck, Celgene vet Zaller as new CSO
19 Aug 2020 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.